Chain for claim_77b3b54dad4f4b45
8 nodes. Root first; inputs below.
depth 0 · claim · via classify
claim_77b3b54dad4f4b45
# Alpha memo — acarbose **Headline:** Polypharmacy Strategies with Acarbose for Dementia Risk Reduction in Type 2 Diabetes: Evidence from Subgroup Analyses and Combination Therapy **Confidence:** `evidence_backed_signal` **Memo surface:** `alpha memo` **Snapshot:** `2026-05-27T09-58-52Z` **Run:** `acarbose-evidence-2026-05-27T09-58-52Z` **Direct source breadth:** `5` direct cited source(s) **Sour…
sha256 d170178dd79ad64f…
depth 1 · source
source_64d901974dea41c3
# Alpha memo — acarbose **Headline:** Polypharmacy Strategies with Acarbose for Dementia Risk Reduction in Type 2 Diabetes: Evidence from Subgroup Analyses and Combination Therapy **Confidence:** `evidence_backed_signal` **Memo surface:** `alpha memo` **Snapshot:** `2026-05-27T09-58-52Z` **Run:** `acarbose-evidence-2026-05-27T09-58-52Z` **Direct source breadth:** `5` direct cited source(s) **Sour…
sha256 f5ce5cafd7875cc3…
depth 1 · source
source_3802f09507f5469b
{"publication_id": "8b15f6df-c45d-4575-89cb-441c5de831bd", "traces": [{"candidate_sources": [{"doi": "10.14336/ad.2019.0621", "study": "Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone", "url": null}, {"doi": "10.3346/jkms.2014.29.1.90", "study": "Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled w…
sha256 e487f6f97e04768b…
depth 1 · source
source_c0e135cd3129475d
{"content_hash": null, "edges": [{"from": "8b15f6df-c45d-4575-89cb-441c5de831bd", "to": "claim_1", "type": "contains_claim"}, {"from": "8b15f6df-c45d-4575-89cb-441c5de831bd", "to": "claim_2", "type": "contains_claim"}, {"from": "8b15f6df-c45d-4575-89cb-441c5de831bd", "to": "claim_3", "type": "contains_claim"}, {"from": "8b15f6df-c45d-4575-89cb-441c5de831bd", "to": "claim_4", "type": "contains_clai…
sha256 aa046019d931e2cd…
depth 1 · source
source_9852ca3314d0419b
{"contradictions": ["Real tension: Acarbose increased median lifespan by 22% in male mice but only 5% in female mice (facts 3,4), whereas in human T2D patients, it reduced dementia risk only in women with an HR of 0.783 (fact 12)."], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not …
sha256 0b2031dccd356e23…
depth 1 · source
source_af240262d65e4aa2
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Contr…
sha256 d9ea5e62eceb2138…
depth 1 · source
source_721466adbaed4e76
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "8b15f6df-c45d-4575-89cb-441c5de831bd", "sources": [{"directness": "primary", "doi": "10.14336/ad.2019.0621", "risk_of_bias": "not appraised in public sidecar", "study": "Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joi…
sha256 2053b861b56ae070…
depth 1 · source
source_e2486c4cd6da4c18
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 dc793781ad96779c…